FUSE MEDICAL, INC.: total assets
Total assets for FUSE MEDICAL, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All FUSE MEDICAL, INC. financial histories
What this measure means
Resources recognized on the balance sheet. Book assets are not the market value of the business.
Exact concept: us-gaap:Assets. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2011-08-31 to 2022-12-31. The SEC response was captured on 2026-09-19.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2022-12-31 | 19,762,581 | USD | 2023-04-14 | 10-K · 0001564590-23-005716 |
| At date | 2021-12-31 | 18,304,492 | USD | 2023-04-14 | 10-K · 0001564590-23-005716 |
| At date | 2020-12-31 | 17,419,237 | USD | 2022-03-31 | 10-K · 0001564590-22-013025 |
| At date | 2019-12-31 | 18,381,491 | USD | 2021-03-31 | 10-K · 0001564590-21-016781 |
| At date | 2018-12-31 | 22,172,851 | USD | 2020-03-30 | 10-K · 0001564590-20-014068 |
| At date | 2017-12-31 | 19,247,155 | USD | 2019-03-21 | 10-K · 0001564590-19-008819 |
| At date | 2016-12-31 | 19,575,798 | USD | 2018-09-21 | 10-K/A · 0001193125-18-280111 |
| At date | 2015-12-31 | 435,005 | USD | 2017-03-20 | 10-K · 0001564590-17-004799 |
| At date | 2014-12-31 | 545,873 | USD | 2016-03-25 | 10-K · 0001477932-16-009171 |
| At date | 2013-12-31 | 535,018 | USD | 2015-04-15 | 10-K · 0001477932-15-002524 |
| At date | 2013-08-31 | 11,501 | USD | 2013-11-15 | 10-K · 0001477932-13-005657 |
| At date | 2012-08-31 | 5,524 | USD | 2013-11-15 | 10-K · 0001477932-13-005657 |
| At date | 2011-08-31 | 65,318 | USD | 2012-12-13 | 10-K · 0001477932-12-004846 |
Related financial histories
- FUSE MEDICAL, INC.: total liabilities
- FUSE MEDICAL, INC.: stockholders equity
- FUSE MEDICAL, INC.: cash and cash equivalents
- FUSE MEDICAL, INC.: net income or loss
- FUSE MEDICAL, INC.: operating cash flow
- FUSE MEDICAL, INC.: capital expenditure payments
- FUSE MEDICAL, INC.: revenue
- FUSE MEDICAL, INC.: contract revenue excluding tax
- FUSE MEDICAL, INC.: financing cash flow
- FUSE MEDICAL, INC.: investing cash flow
- FUSE MEDICAL, INC.: retained earnings or deficit
- FUSE MEDICAL, INC.: basic weighted-average shares
- FUSE MEDICAL, INC.: diluted weighted-average shares
- FUSE MEDICAL, INC.: basic earnings per share
- FUSE MEDICAL, INC.: diluted earnings per share
- FUSE MEDICAL, INC.: income tax expense or benefit
- FUSE MEDICAL, INC.: net property, plant and equipment
- FUSE MEDICAL, INC.: share-based compensation expense
- FUSE MEDICAL, INC.: operating income or loss
- FUSE MEDICAL, INC.: current assets
- FUSE MEDICAL, INC.: interest expense
- FUSE MEDICAL, INC.: current liabilities
- FUSE MEDICAL, INC.: current accounts payable
- FUSE MEDICAL, INC.: goodwill carrying amount
- FUSE MEDICAL, INC.: net finite-lived intangible assets
- FUSE MEDICAL, INC.: net current accounts receivable
- FUSE MEDICAL, INC.: operating expenses
- FUSE MEDICAL, INC.: net inventory
- FUSE MEDICAL, INC.: gross profit
- FUSE MEDICAL, INC.: cost of revenue
- FUSE MEDICAL, INC.: selling, general and administrative expense
Inspect the source
- Entity
- FUSE MEDICAL, INC. / CIK 0000319016
- Captured
- 2026-09-19T11:14:02.031Z
- SEC response SHA-256
13d41024642d3becfdbc15fe6e31fdae11d4fa7a32679fcba6c1a612c57d756a
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000319016.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))